The Molecular Diagnostics market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others. The global Molecular Diagnostics market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The report also bifurcates the global Molecular Diagnostics market based on End User in Hospital and Academic Laboratories, Reference Laboratories, and Other End-Users. Based on Technology the global Molecular Diagnostics market is segmented in Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing and NGS, DNA Microarrays, In Situ Hybridization, and Other Technologies.īased on Application, the global Molecular Diagnostics market is segmented in Infectious Disease, Oncology, Genetic Tests, and Other Applications.
MOLECULAR DIAGNOSTICS MARKET SIZE SOFTWARE
The global Molecular Diagnostics market is segregated on the basis of Product & Service as Reagents & Kits, Instruments, and Software and Service. Nevertheless, increase in adoption of the molecular diagnostics within the emerging economies provide growth opportunities for the market. Stringent regulatory requirements for the approval of latest molecular diagnostics techniques hampers the expansion of the market. The factors such growth within the prevalence of the infectious diseases and various sorts of cancer, rise in awareness and acceptance of personalized medicines, growth within the biomarker identification, and advancement in molecular diagnostics drive the market growth. and is additionally wont to check the genetic predisposition to a disease. These techniques are used for diagnosis of the varied infectious diseases, cancer, etc. These are cumulative techniques for analysing biological markers at the molecular level, like genome and proteome. Molecular diagnostic tests are wont to detect specific sequences in DNA or RNA, including single nucleotide polymorphism (SNP), deletions, rearrangements, insertions, etc.
The Global Molecular Diagnostics Market is expected to be around US$ 17.10 billion by 2028 and will grow at a CAGR of more than 9% in the given forecast period.
0 kommentar(er)
